LIPOSOMAL DRY POWDER INHALER: NOVEL PULMONARY TARGETED DRUG DELIVERY SYSTEM FOR THE TREATMENT OF LUNG CANCER

Lung cancer is a great evil doer behind mortality around the world. The degree of lung patients in developing nations has grown from 31% to 49.9% over recent 20 y. Despite current upgrades chemotherapy, death rate high. Generally, chemotherapy accompanied by most side effects. If an anticancer drug could deliver only right site concentration at time, be cured without A liposomal dry powder inhaler (LDPI) innovative strategy convey particles. (DPI) unique features such as targeted delivery, improved bioavailability, and better therapeutic efficacy embedded drug's ability constant rate. This paper emphasizes utility liposomes DPI therapy, commonly used formulation techniques for manufacturing LDPI, various devices formulation, ongoing recently concluded clinical trials. Patents filed multiple researchers future perspective LDPI delivery system promising systems administering wide variety drugs, including anti-cancer are described cancer.